FILING ANALYSIS · THURSDAY, OCTOBER 29
Indivior Pharmaceuticals, Inc. INDV — 8-K: Results of Operations and Financial Condition
positive
Indivior reported a 13% year-over-year increase in total net revenue and a 22% increase in SUBLOCADE net revenue, with GAAP net income of $137 million and non-GAAP net income of $161 million, exceeding expectations and indicating a strong quarter for the company.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →